Bayer has announced a recall of two lots of Kogenate® FS 2000 IU vials.
PrintFriendly
-
Medical Advisory #425: Bayer Announces a Voluntary Recall of Two Lots of Kogenate FS
-
uniQure Announces New Gene Therapy Trial Data at ISTH
uniQure's gene therapy candidate AMT-061 is being developed for individuals with severe and moderately severe hemophilia B.
-
Genentech Announces New Data from Hemlibra® Clinical Trial Program
Much of the data was gleaned from the HAVEN clinical trial program.
-
Octapharma Presents Final Data on Personalized Therapy with Nuwiq®
The final data included here was presented for the first time at a symposium held during the XXVII Congress of the International Society on Thrombosis and Haemostasis (ISTH).
-
NHF Joins Organizations Urging Court to Protect ACA
Protections for pre-existing conditions and coverage standards at risk
-
A Priceless Experience
NHF's Connections for Learning program brings families education and support.
-
Sangamo and Pfizer Announce Interim Gene Therapy Findings
The findings presented at ISTH were based on an ongoing phase 1/2 clinical trial in patients with severe hemophilia A.
-
Comparing Adherence and Physical Activity in Hemophilia A Patients
The findings of a new study suggest several areas of impact relevant to adherence and physical activity for patients with severe hemophilia A.